Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. How to Control Eye Pressure in Glaucoma The irreversible damage of glaucoma is one of the leading causes of blindness among people ages 60 years and above(1). This condition is
Tag: ophthalmologist
Optic 3D Modeling in Ophthalmic Treatment
Optic 3D Modeling in Ophthalmic Treatment Visual impairment is a global health concern. Visually impaired patients are at high risk for accidents, depression, and social withdrawal. Eye disorders like age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP) cause irreparable vision loss and affect the quality of life of
iStent Combination Therapy for Glaucoma and Cataracts
iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value.
Second Primary Malignancies of Eye and Ocular Adnexa
Thermography in clinical ophthalmic oncology
THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest
Combination IOP Reduction Therapy in Open-Angle Glaucoma
Combination IOP Reduction Therapy in Open-Angle Glaucoma GLAUCOMA BACKGROUND Globally, glaucoma is a leading cause of permanent blindness. As of 2020, about 80 million people worldwide, and 3 million Americans, are affected by glaucoma. The most common form of glaucoma is open-angle glaucoma. Unfortunately, the primary risk factor for open-angle glaucoma is
Involvement of Ocular Surface in Graft‐Versus‐Host Disease: A Review
Involvement of Ocular Surface in Graft-Versus-Host Disease: A Review Hematopoietic stem cell transplantation (HSCT) is a promising curative therapy for hematologic malignancies and other disorders of blood and bone marrow. Historically, HSCT was referred to as bone marrow transplantation (BMT) because bone marrow was the sole source of transplanted hematopoietic stem
Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions
Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions Most orbital space-occupying lesions come from tissues in the orbital space or metastasize from other system tumors. The bulk of clinical manifestations of these lesions such as diplopia, protrusion, and loss of vision are often nonspecific, so imaging technology is crucial
Risk Factors for Ocular Metastases in Invasive Ductal Carcinoma
Myelofibrosis – Biology, Management, and Case Report of Ocular Manifestation
MF-BIOLOGY, MANAGEMENT, AND CASE REPORT OF OCULAR MANIFESTATION Myelofibrosis is an uncommon myeloproliferative neoplasm, a type of blood cancer where excess red blood cells, white blood cells, or platelets are produced in the bone marrow. The rarity of this abnormality has many medical professionals struggling to understand its genetic underpinnings. This
